Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LITHIUM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | LITHIUM |
| Key Genes/Proteins | GSK3B, BDNF, AMYLOID |
| Related Diseases | DEPRESSION, CHEMOBRAIN, APOPTOSIS, AUTOPHAGY, NEURODEGENERATION |
Knowledge base pages for this entity
graph TD
LITHIUM["LITHIUM"]
LITHIUM -->|"treats"| bipolar_disorder["bipolar disorder"]
LITHIUM -->|"inhibits"| dopamine_synthesis["dopamine synthesis"]
LITHIUM -->|"enhances"| AUTOPHAGY["AUTOPHAGY"]
LITHIUM -->|"expressed in"| Brain["Brain"]
LITHIUM -->|"activates"| MAPK_signaling["MAPK signaling"]
LITHIUM -->|"upregulates"| BETA_CATENIN["BETA-CATENIN"]
LITHIUM -->|"modulates"| BDNF["BDNF"]
AUTOPHAGY -->|"promotes"| LITHIUM
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"depletes"| LITHIUM
ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"activates"| LITHIUM| Target | Relation | Type | Str |
|---|---|---|---|
| GSK3B | inhibits | gene | 0.80 |
| DEPRESSION | treats | disease | 0.80 |
| CHEMOBRAIN | treats | disease | 0.80 |
| APOPTOSIS | protects_against | phenotype | 0.70 |
| APOPTOSIS | activates | phenotype | 0.70 |
| AUTOPHAGY | protects_against | phenotype | 0.65 |
| BDNF | inhibits | gene | 0.65 |
| BDNF | activates | gene | 0.65 |
| NEURODEGENERATION | inhibits | disease | 0.65 |
| NEURODEGENERATION | activates | disease | 0.65 |
| SENESCENCE | inhibits | phenotype | 0.65 |
| AMYLOID | protects_against | protein | 0.65 |
| DEPRESSION | inhibits | disease | 0.65 |
| DEPRESSION | activates | disease | 0.65 |
| BDNF | synergizes_with | gene | 0.60 |
| PARKINSON'S DISEASE | depleted_in | disease | 0.55 |
| AGING | implicated_in | phenotype | 0.55 |
| NEURONS | associated_with | cell_type | 0.50 |
| BDNF | associated_with | gene | 0.50 |
| APP | associated_with | gene | 0.50 |
| TAU | associated_with | protein | 0.50 |
| GLUT4 | associated_with | gene | 0.50 |
| PI3K | associated_with | gene | 0.50 |
| AMPK | associated_with | gene | 0.50 |
| AKT | associated_with | gene | 0.50 |
| JNK | associated_with | gene | 0.50 |
| CSF | associated_with | phenotype | 0.50 |
| MELANOMA | associated_with | disease | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
| MTOR | associated_with | gene | 0.45 |
| NRF2 | associated_with | gene | 0.45 |
| CORTEX | associated_with | brain_region | 0.45 |
| AGING | associated_with | phenotype | 0.45 |
| AMYLOID | associated_with | protein | 0.45 |
| HDAC6 | associated_with | gene | 0.45 |
| MAPK | associated_with | gene | 0.45 |
| NEUROTOXICITY | associated_with | process | 0.35 |
| PARKINSON'S DISEASE | activates | disease | 0.35 |
| MELANOMA | activates | disease | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURONS | interacts_with | cell_type | 0.70 |
| CELL SURVIVAL | associated_with | phenotype | 0.50 |
| APOPTOSIS | associated_with | phenotype | 0.50 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.50 |
| DIABETES | associated_with | disease | 0.50 |
| WNT SIGNALING | associated_with | pathway | 0.50 |
| TAU PHOSPHORYLATION | associated_with | phenotype | 0.50 |
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| BIPOLAR DISORDER | associated_with | disease | 0.50 |
| FIBROBLASTS | associated_with | cell_type | 0.50 |
| FERROPTOSIS | associated_with | phenotype | 0.50 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
| MELANOMA | associated_with | disease | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| AMYLOID-BETA | associated_with | protein | 0.45 |
| EPILEPSY | associated_with | disease | 0.45 |
| SENESCENCE | associated_with | phenotype | 0.45 |
| VALPROIC ACID | associated_with | drug | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| NEUROFIBRILLARY TANGLES | associated_with | phenotype | 0.45 |
| DEPRESSION | associated_with | disease | 0.45 |
| TIDEGLUSIB | associated_with | drug | 0.45 |
| ALZHEIMER'S DISEASE | depletes | disease | 0.35 |
| ALPHA-SYNUCLEIN | activates | gene | 0.35 |
| AUTOPHAGY | activates | process | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||